Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: Clinical and angiographic safety profile

Marco Valgimigli, Gian Matteo Rigolin, Corrado Cittanti, Patrizia Malagutti, Salvatore Curello, Gianfranco Percoco, Anna Maria Bugli, Matteo Della Porta, Letizia Zenone Bragotti, Lucia Ansani, Endri Mauro, Arnalda Lanfranchi, Melchiore Giganti, Luciano Feggi, Gianluigi Castoldi, Roberto Ferrari

Research output: Contribution to journalArticlepeer-review

Abstract

Aims: There is increasing evidence that stem cell (SC) mobilization to the heart and their differentiation into cardiac cells is a naturally occurring process. We sought to assess the safety and feasibility of granulocyte-colony stimulating factor (G-CSF) administration in humans to enhance SC mobilization and left ventricle (LV) injury repair during myocardial infarction (MI). Methods and results: Twenty patients with STEMI (mean age, 61 ± 10 years), of whom 14 were submitted to primary percutaneous coronary intervention, were randomized to G-CSF (5 μg/kg/day s.c. for 4 consecutive days) or placebo. At entry and then at months 3 and 6, 99mTc-sestamibi gated-SPECT was performed to estimate extension of perfusion defect (PD) and LV function. The study drug was well tolerated and induced a significant increase of white blood count, CD34+ cells, and CD34+ cells coexpressing AC133 and VEGFR-2. At follow-up, treated and placebo groups did not differ for the angiographic coronary late loss and showed a similar pattern of PD recovery, whereas in the former at 6 months LVEF and especially LVEDV tended to be relatively higher (P = 0.068) and lower (P = 0.054), respectively. Conclusion G-CSF administration in acute MI patients was feasible and did not lead to any clinical or angiographic adverse events and resulted in CD34+ and CD34+AC133+VEGFR2+ cell mobilization.

Original languageEnglish
Pages (from-to)1838-1845
Number of pages8
JournalEuropean Heart Journal
Volume26
Issue number18
DOIs
Publication statusPublished - Sep 2005

Keywords

  • CD34
  • Endothelial progenitor cells
  • Granulocyte-colony stimulating factor
  • Myocardial infarction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: Clinical and angiographic safety profile'. Together they form a unique fingerprint.

Cite this